Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

204
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

347
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
347
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Hepatic Portal System01:21

Hepatic Portal System

5.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of Nonreciprocal Directional Dichroism in Bi_{2}CuO_{4} Using Electric and Magnetic Fields of an Intense Terahertz Pulse.

Physical review letters·2025
Same author

Factors associated with changes in tacrolimus blood concentration after food initiation in patients with ulcerative colitis.

Die Pharmazie·2024
Same author

Retrospective analysis of risk factors for liposomal amphotericin B-associated nephrotoxicity.

Die Pharmazie·2020
Same author

Development of a high-hydrous gel phantom for human body communication based on electrical anisotropy.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
Same author

ANCA-associated small-vessel vasculitis surrounding the temporal artery.

QJM : monthly journal of the Association of Physicians·2017
Same author

Langerhans cell-like dendritic cells stimulated with an adjuvant direct the development of Th1 and Th2 cells in vivo.

Clinical and experimental immunology·2015
Same journal

TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

Human pathology·2026
Same journal

Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

Human pathology·2026
Same journal

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same journal

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

Human pathology·2026
Same journal

Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

Human pathology·2026
Same journal

Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

Human pathology·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

15.3K

Hepatic infarction

T T Seeley, C M Blumenfeld, R Ikeda

    Human Pathology
    |June 1, 1972
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Myocardial Infarction and Functional Outcome Assessment in Pigs
    12:03

    Myocardial Infarction and Functional Outcome Assessment in Pigs

    Published on: April 25, 2014

    28.6K
    Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels
    13:16

    Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels

    Published on: January 4, 2013

    16.0K

    Related Experiment Videos

    Last Updated: Jan 10, 2026

    Histological Quantification of Chronic Myocardial Infarct in Rats
    09:45

    Histological Quantification of Chronic Myocardial Infarct in Rats

    Published on: December 11, 2016

    15.3K
    Myocardial Infarction and Functional Outcome Assessment in Pigs
    12:03

    Myocardial Infarction and Functional Outcome Assessment in Pigs

    Published on: April 25, 2014

    28.6K
    Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels
    13:16

    Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels

    Published on: January 4, 2013

    16.0K